These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 11694848)

  • 1. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
    Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
    J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
    Van Kuyk R; Mosier DE
    Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
    De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
    Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistence of hepatitis C virus type II in patient's peripheral blood B lymphocytes transformed by Epstein-Barr virus].
    Cheng J; Chen L; Tong W
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):349-53. PubMed ID: 11798785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
    Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
    J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells.
    Colombrino E; Rossi E; Ballon G; Terrin L; Indraccolo S; Chieco-Bianchi L; De Rossi A
    Exp Cell Res; 2004 May; 295(2):539-48. PubMed ID: 15093750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma.
    Fellner MD; Durand K; Correa RM; Redini L; Yampolsky C; Colobraro A; Sevlever G; Teyssié AR; Benetucci J; Picconi MA
    Int J Infect Dis; 2007 Mar; 11(2):172-8. PubMed ID: 16931088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
    Honda S; Takasaki T; Okuno K; Yasutomi M; Kurane I
    Acta Virol; 1998 Nov; 42(5):307-13. PubMed ID: 10358731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.
    Richard Y; Amiel C; Jeantils V; Mestivier D; Portier A; Dhello G; Feuillard J; Creidy R; Nicolas JC; Raphael M
    J Infect Dis; 2010 Nov; 202(9):1424-34. PubMed ID: 20874514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.
    Gudgeon NH; Taylor GS; Long HM; Haigh TA; Rickinson AB
    J Virol; 2005 May; 79(9):5477-88. PubMed ID: 15827162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus.
    Zhang RD; Henderson EE
    Virology; 1994 Feb; 198(2):709-13. PubMed ID: 7507284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.
    Gregory CD; Kirchgens C; Edwards CF; Young LS; Rowe M; Forster A; Rabbitts TH; Rickinson AB
    Eur J Immunol; 1987 Aug; 17(8):1199-207. PubMed ID: 3040424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
    Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH
    J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.